News, views and contacts from the global Drugdevelopment industry
 


Eli Lilly conducted phase III clinical trials on Cymbalta from July 2009 to May 2010. The study enrolled 420 patients and compared the efficacy of 60mg of Cymbalta to a placebo to assess the effect of the drug in reducing the pain effect caused by knee osteoarthritis.


Back to Project Details